NICE nod for Almirall’s Ilumetri, UCB’s Cimzia
NICE has recommended Almirall’s Ilumetri and UCB’s Cimzia as treatment options for severe plaque psoriasis in final draft guidelines.
Read More
Tag: systemic non-biological treatments
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
